Diabetes Australia funding important research into heart health 4 September 2017 Heart disease is one of the most common and serious complications of diabetes. It refers to a number of heart-related conditions including cardiomyopathy. This week for Cardiomyopathy Week we are highlighting some of the research Diabetes Australia is funding in this important area. Cardiomyopathy refers to a condition where the heart is unable to pump enough blood around the body. It effects the heart’s ability to relax and refill with blood which is essential to its proper functioning. Symptoms of cardiomyopathy include breathlessness, tiredness and swelling in the legs and abdomen. Current heart disease treatments for people with diabetes have a limited effect. That is why Diabetes Australia is helping to fund research into new treatments and therapies to help preserve heart function in people with diabetes. Dr Mitchel Tate, a Research Officer at the Baker Heart and Diabetes Institute, is currently working on a Diabetes Australia Research Trust-funded project to develop new therapies for treating diabetes-related heart disease. Dr Tate is investigating the potential use of gene therapy in diabetic cardiomyopathy in order to help preserve heart function. This approach may have a number of advantages including its long-lasting effects and its ability to be targeted at a specific organ, in this case the heart. “One target of interest is bone morphogenetic protein 7 (BMP7), and despite its name, is an important inhibitor of the TGF-β signalling cascade that induces fibrosis; cardiac fibrosis being a prominent feature of the diabetic heart. Importantly, this approach has shown promise in other diabetic complications including chronic kidney disease and may represent a viable treatment option,” he said “Currently, though there are medicines available to lower blood pressure or prevent blood clots from forming, in cases of cardiomyopathy the most common recommendation for treatment is a healthy diet and physical activity.” It is also recommended that people at risk of developing cardiomyopathy make several lifestyle changes designed to manage any conditions that cause or contribute to the disease, such as quitting smoking, avoiding alcohol, losing excess weight and avoiding a salt-heavy diet, reducing stress and getting enough rest. If you are concerned about potential of heart disease you can contact your doctor. For more information visit https://www.heartfoundation.org.au.
Partners 1 June 2026 Does your CGM meet anzCGM standards? Advertisement When you live with diabetes, glucose readings influence everyday choices: from food and exercise to conversations with your healthcare... Continue Reading
Blog 1 June 2026 Life on the level podcast: returning for season 2 Life on the Level podcast is back with season 2. Hosted by young Aussies Isabella Magee and Sebastian Harris, this season explores what it's really like to live with type 1 diabetes; the challenges, the wins, and all the messy bits in between. Continue Reading
Blog 1 June 2026 Rebuilding after the fall: Brett Findlay’s story of recovery and resilience Brett Findlay had just started a new job when he learnt he had type 1 diabetes. He figured he could manage diabetes by keeping his blood glucose levels consistently low. Then, one fateful day, he had a severe hypo. In this raw episode of Life on the Level, Brett talks about hypo unawareness, rebuilding after trauma, and the enduring strength of family. Continue Reading